March 2017 FDA Recall Atorvastatin Calcium by Mylan Institutional, Inc. (d.b.a. Udl Laboratories) (D-0622-2017 - Microbial Contamination of Non-Sterile Products)

This Class II drug recall was voluntarily initiated by Mylan Institutional, Inc. (d.b.a. Udl Laboratories) on March 21, 2017 for the product Atorvastatin Calcium. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0622-2017

Reason for Recall
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Initiated
03-21-2017
Reported
04-05-2017
Quantity
1,527 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Nationwide in the USA
Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20

Batch or Lot Expiration Information

Lot# : 3084288, Exp. 07/18